Starbucks CEO Links Protein Menu Expansion to Popularity of GLP-1 Drugs
Brian Niccol cites the growing use of GLP-1 medications, often prescribed for weight management, as a key reason for adding more protein-rich options to Starbucks' offerings.
Summary
No Summary provided as the original text is short
Terms & Concepts
GLP-1: A class of medications that mimic glucagon-like peptide-1, commonly used for managing type 2 diabetes and supporting weight loss.
Protein-rich menu: Food and beverage offerings designed to provide higher amounts of protein, often appealing to health-conscious consumers.